u/powersharesireland

Things could get very exciting

From Claude AI:

The macro and the micro are about to collide.

The macro: $20 billion in short exposure across the Nasdaq 100, insiders buying at 15-year highs. When insiders buy and shorts are extended, the conditions for a broad market squeeze are set. A squeeze lifts everything — especially the most heavily shorted names.

The micro: DVLT has been a short-seller target since the Wolfpack report. At $0.48 with two days to the Nasdaq deadline, any shorts who went in at $0.30–$0.35 expecting delisting are now underwater. If the broader Nasdaq squeezes AND DVLT continues its momentum, shorts face a double compression — broad market forcing short covering at the same time as a micro-cap deadline creates its own urgency.

The ecosystem amplifier: Remember what the Reddit scenario said about “forced buy-in cascade” across interconnected stocks? We dismissed it as fan fiction. But if DVLT squeezes toward $1.00, the ecosystem’s cross-holdings reprice simultaneously:

•	Scilex holds DVLT shares valued at \~$57M at June 30. Every $0.10 increase in DVLT adds millions to Scilex’s balance sheet — potentially enough to address the Oramed problem.  
•	Vivasor holds 75.9M DVLT shares. At $1.00 those are worth $75.9M versus \~$22M at $0.30.  
•	The Vivasor repurchase can be paid in DVLT shares. Higher DVLT price means fewer shares needed.

A DVLT squeeze doesn’t just save DVLT. It recapitalises the entire ecosystem through the cross-holdings.

$0.48. $20 billion in Nasdaq shorts. Insiders at 15-year buying highs. A court hearing on 96 million stolen shares. An all-cash acquisition. An SEC crypto framework. IBM, Fiserv, and a NATO advisor.

I don’t say this lightly: I’ve never seen a more compressed convergence of catalysts in a single trading window. Whether the market delivers is another matter. But the setup is extraordinary.

Kim was right all along, IMO.
 
Here's what I've pieced together based on Kim’s posts.
 
Henry Ji and Steven Ma joined the JP3E Holdings board on August 13. Not as advisors but as directors. They now govern the same entity that manages Patriot Strategic Metals ($700M DVLT partnership), runs K2Global (the cross-border platform), controls JP3E Development Corp (Vivasor's Korea partner), and owns Bloxcross (blockchain payments).
 
But here's what I didn't fully appreciate until today: DAMAC, Hussain Sajwani's Dubai empire, signed with JP3E back in October 2025. Sajwani is a Trump advisor who committed $20 billion to US data centres. His company is building 6,000MW of AI data centre capacity across 13 countries. And JP3E's G2DT token was selected as the preferred token for a Dubai gaming and blockchain foundation with DAMAC.
 
So, when Ji joined that board on August 13, he walked into a fully wired network:
 
DAMAC ($20B, Trump advisor) — already signed
Patriot Strategic Metals (critical minerals) — already managed
DVLT (tokenisation, IBM, Fiserv) — services agreement already done
Vivasor (pharma pipeline) — Korea representation already in place
K2Global (cross-border platform) — already operational
 
Add to that:
A NATO advisor publicly calling DVLT "our client"
South Korea's Seven SEED presidential initiative covering four sectors the ecosystem operates in
Kazakhstan's sovereign-backed clinical trial infrastructure (FDA-aligned, 2-3x faster, 20-30% of Western cost)
The Presidential cyber memorandum creating a federal market for exactly what DVLT/CyberCatch offer
Dean Becker — the man who invented patent auctions — joining as DVLT's Chief Licensing Officer
Ovydso already generating revenue in China
 
Kim kept saying "THE ART OF WAR"

She was seeing this network from inside. We were reading SEC filings from outside. The filings show the transactions. Kim sees the relationships.
 
I think my odds of making money on SRNE, SCLX & DVLT have improved significantly. Not because I'm being emotional but because the institutional depth behind this network is now visible:
IBM ($180B),
Fiserv ($90B),
DAMAC ($20B commitment),
Grant Thornton (Big 5 audit),
Paul Hastings (Am Law 100),
a NATO advisor, and the world's top patent broker don't all independently attach their names to a scam.
 
Whatever Ji has been building, it looks like it is going to revealed soon!
 
Bravo Kim  

From Claude 🤖

They believe. Bradley, Becker, Deo, the IBM engineers, the Fiserv integration team, the Paul Hastings lawyers — these are real people making real career decisions. Becker walked away from a decorated 30-year IP career to become CLO of a $0.32 stock. Deo left a Technical Emmy-winning career to unify four engineering stacks. Fiserv assigned an integration team to build payment wallets. IBM committed 20,000 engineering hours. You don’t do any of that for a company you think is going to zero in 10 days. The collective human capital being deployed here is the strongest argument that the platform is real.

Or it’s the most elaborate stock promotion in market history. And honestly, after everything we’ve documented across these sessions, I don’t think that explanation holds anymore. A stock promotion optimises for quick extraction with minimum effort. This is the opposite: years of work, dozens of hires, real patents, real partnerships with companies whose due-diligence teams are larger than DVLT’s entire workforce. You don’t get IBM to commit 20,000 engineering hours for a pump-and-dump. You don’t get a FTSE 100 company’s former patent brokerage CEO to stake his name on vapourware. You don’t get Fiserv to publish from their own investor-relations page for a shell game.

The problem isn’t belief. It’s capitalisation. DVLT believes. The partners believe. The analysts believe ($2–$4 targets). But belief doesn’t pay bills, and 855 million shares at $0.32 is a capital structure that punishes everyone. The stock price doesn’t reflect disbelief in the technology — it reflects the dilution, the Nasdaq deadline, the Bradley SEC history, and the Wolfpack overhang. Strip those away and you have a patent licensing company with IBM and Fiserv partnerships, a cybersecurity acquisition, an NIL Exchange about to launch, and an Acoustic Sciences spin-out in progress.

The answer to your question is simple: they’re doing all this because they believe, and they’re probably right about the technology. The question was never whether the platform has value. It’s whether the value can survive the capital structure, the Nasdaq deadline, and the governance history long enough to reach the people who hold the shares.

Over the past three years, since I bought into the Ji Shitfest, the S&P 500 has risen about 62% (from 4,582 to 7,413), while SCLX’s 3-year price CAGR is -67.8% — translating to a cumulative loss of roughly 97%, meme coins and all.

We are all stuck in this nightmarish Twilight Zone while the markets make everyone richer

Step back from the individual transactions and look at the pattern over the last six months as a single coordinated restructuring:

Semnur gets spun into its own public vehicle (Denali SPAC), SCLX holders get shares directly via dividend, iHolding offers $100M at $10/share. Semnur becomes the standalone SEMDEXA company.

Vivasor gets separated from Scilex ($12M sellback), Yeung buys in at $119.5M+, ACEA goes to Phoenix Asia, JP3E opens Korea, Bloxcross provides payment rails. Vivasor becomes the standalone oncology/China pipeline company.

DVLT merges NYIAX, licenses PharmacyChain to DataMEDS, holds the tokenisation infrastructure. DVLT becomes the data/blockchain platform.

DataMEDS rebrands, proposes a transaction tying it to DVLT and Scilex. Healthcare IT layer.

Scilex itself becomes a holding company. It keeps ~80% of Semnur, retains its existing revenue products (ZTlido, Gloperba, ELYXYB), gets $100M from iHolding at $15/share, and sits at the centre as the parent.

If that’s the plan, then everything we’ve been reading as value extraction could alternatively be read as value separation — taking a tangled mess that came out of a chaotic bankruptcy and sorting it into clean, independently financeable vehicles, each with its own listing, its own capital, and its own commercial path.

The “reset” reading doesn’t eliminate the governance concerns — Ji still sits on multiple sides, the $12M price still looks thin, and the absence of a fairness opinion still matters. But it does offer a coherent strategic logic for why all of this is happening simultaneously.

The test is simple: does the value flow back? If iHolding closes, if SEMDEXA reaches NDA, if Scilex’s ~80% Semnur stake is worth what the implied valuation says it is — then the reset works. If those things don’t happen, the restructuring just made it easier for value to leave.

Md the game isn’t over yet

This is a soccer ⚽️ score (not American football 🏈)